Iovance Biotherapeutics, Inc. (IOVA) shares outstanding

Shares outstanding · fiscal 2025
357.35M

Iovance Biotherapeutics, Inc. (IOVA) had 357.35M diluted shares on average in fiscal 2025 (the year ended December 31, 2025). That is 23.3% higher than the 289.88M of fiscal 2024. Figures as of 18 Nov 2026, 11:33 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Shares outstanding, fiscal 2025
357.35M
Change on fiscal 2024
+23.3%
Growth, 5 years
+20.9% a year
Highest on record
357.35Mfiscal 2025
Lowest on record
124.25Mfiscal 2019
Fiscal years on record
72019–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Figures, not advice.

Iovance Biotherapeutics, Inc. shares outstanding, in more detail

The market data feed counts 462.66M shares outstanding today.

Over the five fiscal years to 2025 the diluted share count grew at a compound 20.9% a year. Across the 7 fiscal years on record (2019–2025), the highest was 357.35M in fiscal 2025 and the lowest 124.25M in fiscal 2019.

History · 7 fiscal years

Shares outstanding by fiscal year

Iovance Biotherapeutics, Inc. shares outstanding, year by year

Iovance Biotherapeutics, Inc. (IOVA) shares outstanding by fiscal year
Fiscal yearShares outstandingChangeYear ended
2025357.35M 23.3% up
2024289.88M 23.3% up
2023235.13M 47.6% up
2022159.26M 3.8% up
2021153.48M 11.2% up
2020138.08M 11.1% up
2019124.25M—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

The share count for each fiscal year is the diluted weighted average the company reports with its earnings per share, re-based for later stock splits; the number outstanding today comes from the market data feed.

How to read it

A falling count means buybacks are giving each remaining share a larger slice of the company; a rising one means owners are being diluted.

More on IOVA

Iovance Biotherapeutics, Inc., figure by figure

Iovance Biotherapeutics, Inc. (IOVA) overview: price, valuation and scorecard

Iovance Biotherapeutics, Inc. shares outstanding: questions and answers

How many shares does Iovance Biotherapeutics, Inc. have?

Iovance Biotherapeutics, Inc. (IOVA) had 357.35M diluted shares on average in fiscal 2025 (the year ended December 31, 2025). That is 23.3% higher than the 289.88M of fiscal 2024. The market data feed counts 462.66M shares outstanding today.

What is the growth rate of Iovance Biotherapeutics, Inc.'s diluted share count?

Over the five fiscal years to 2025 the diluted share count grew at a compound 20.9% a year.

What are the highest and lowest diluted share count figures on record for Iovance Biotherapeutics, Inc.?

Across the 7 fiscal years on record (2019–2025), the highest was 357.35M in fiscal 2025 and the lowest 124.25M in fiscal 2019.

How is Iovance Biotherapeutics, Inc.'s diluted share count calculated?

The share count for each fiscal year is the diluted weighted average the company reports with its earnings per share, re-based for later stock splits; the number outstanding today comes from the market data feed. For Iovance Biotherapeutics, Inc. it is on record here for 7 fiscal years, 2019 to 2025.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Iovance Biotherapeutics, Inc. (IOVA) shares outstanding”, data as of 18 November 2026. https://funkfolio.com/stock/IOVA/shares-outstanding

Underlying data: the company's filings with the SEC and Yahoo Finance.